Market Snapshot
Dow Futures
32,758
S&P Futures
4,127.25
Nasdaq Futures
13,031
Endo International plc (ENDP) stock declined over -18.76% intraday to trade at $0.5427 a share on NASDAQ. The stock opened with a loss of -15.20% at $0.724 and touched an intraday high of $0.745, falling -24.63% against the last close of $0.72. The stock went to a low of $0.65 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-08 | $0.724 | $0.745 | $0.65 | $0.668 | 26,801,195 |
2022-08-05 | $0.64 | $0.75 | $0.61 | $0.72 | 44,865,100 |
2022-08-04 | $0.77 | $0.77 | $0.62 | $0.64 | 49,145,900 |
2022-08-03 | $0.63 | $0.94 | $0.62 | $0.75 | 149,791,700 |
2022-08-02 | $0.52 | $0.61 | $0.51 | $0.58 | 47,916,000 |
2022-08-01 | $0.52 | $0.53 | $0.49 | $0.52 | 13,115,300 |
2022-07-29 | $0.52 | $0.56 | $0.5 | $0.53 | 21,416,200 |
2022-07-28 | $0.52 | $0.55 | $0.47 | $0.53 | 39,448,800 |
2022-07-27 | $0.54 | $0.55 | $0.43 | $0.45 | 29,047,700 |
2022-07-26 | $0.44 | $0.53 | $0.43 | $0.52 | 41,803,700 |
Employees-
Beta1.13
Sales or Revenue2.93 Billion
5Y Sales Change-5.7%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryPharmaceuticals
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
Endo International plc (NASDAQ: ENDP) stock price is $0.5427 as of the last check on Monday, August 8. During the trading session, ENDP stock reached the peak price of $0.745 while $0.65 was the lowest point it dropped to.
The NASDAQ listed ENDP is part of Pharmaceuticals industry that operates in the broader Health Care sector. Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology.
Mr. Joseph A. Barbarite
Exec. VP of Global Quality and Compliance
Mr. Blaise A. Coleman
Pres, CEO & Director
Mr. Mark T. Bradley
Exec. VP & CFO
Mr. Matthew Joseph Maletta
Exec. VP, Chief Legal Officer & Company Sec.
ENDP stock traded closed the last session at $0.668, which is -$0.12530000000000008 or -18.75748502994013% lower than its previous close of $0.72. ENDP's current trading price is 138.57% lower than its 52-week high of $7.07 where as its distance from 52-week low of 0.28% is -90.55%.
Number of ENDP employees currently stands at -. ENDP operates from Minerva House, First Floor Simmonscourt Road Ballsbridge, Dublin 4, Ireland.
Official Webiste of $ENDP is: https://www.endo.com
ENDP could be contacted at ENDP operates from Minerva House, First Floor Simmonscourt Road Ballsbridge, Dublin 4, Ireland, or at phone #353 1 268 2000 and can also be accessed through its website.
ENDP stock volume for the day was 18,233,182 shares while in the previous session number of ENDP shares traded was 26,801,195 . The average number of ENDP shares traded daily for last 3 months was 49.2 Million.
The percentage change in ENDP stock occurred in the recent session was -18.75748502994013% while the dollar amount for the price change in ENDP stock was -$0.12530000000000008.
In the recent session, the day high for ENDP stock was $0.745 while the low for ENDP stock touched on the day was $0.65.
The market value of ENDP currently stands at 139.95 Million with its latest stock price at $0.5427 and 233.88 Million of its shares outstanding.